As depicted in Figure 3, most studies on pancreatic cancer have demonstrated that the deregulated GSK3β sustains tumor cell survival, immortalization, and proliferation - common and fundamental features that engender therapy resistance in nearly all cancer types. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.